Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
The Journal of Vascular Access|March 30, 2018
A novel technique of axillary vein puncture involving peripherally inserted central venous catheters for a small basilic veinFumito Saijo, Yoshinobu Odaka, Mitsuhisa Mutoh, et al.Genes & Cancer|July 7, 2017
Ciclopirox inhibits cancer cell proliferation by suppression of Cdc25ATao Shen, Chaowei Shang, Hongyu Zhou, et al.Carcinogenesis|August 10, 2013
Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cellsYoshinobu Odaka, Baoshan Xu, Yan Luo, et al.Immunology|January 14, 2010
Priming of immune responses against transporter associated with antigen processing (TAP)-deficient tumours: tumour direct primingXiao-Lin Li, Dongqing Zhang, David Knight, et al.Nucleic Acids Research|August 19, 2006
Specific and nontoxic silencing in mammalian cells with expressed long dsRNAsAurel Strat, Lu Gao, Tada Utsuki, et al.Cancer Prevention Research (Philadelphia, Pa.)|April 12, 2012
Cryptotanshinone activates p38/JNK and inhibits Erk1/2 leading to caspase-independent cell death in tumor cellsWenxing Chen, Lei Liu, Yan Luo, et al.Plos One|July 25, 2009
Effect of B7.1 costimulation on T-cell based immunity against TAP-negative cancer can be facilitated by TAP1 expressionXiao-Lin Li, Yong-Yu Liu, David Knight, et al.Neoplasia (New York, N.Y.)|April 13, 2012
Rapamycin inhibits lymphatic endothelial cell tube formation by downregulating vascular endothelial growth factor receptor 3 protein expressionYan Luo, Lei Liu, Donna Rogers, et al.Carcinogenesis|February 3, 2012
Curcumin inhibits protein phosphatases 2A and 5, leading to activation of mitogen-activated protein kinases and death in tumor cellsXiuzhen Han, Baoshan Xu, Christopher S Beevers, et al.Medical Mycology|May 11, 2012
Protothecosis: report of a case with 20-year follow-up, and review of previously published casesJohn R Todd, John W King, Arnold Oberle, et al.Pageof 3